ISSN : 0975-9492
CODEN : IJPSQQ





INTERNATIONAL JOURNAL OF PHARMA SCIENCES AND RESEARCH


Open Access

This website is certified by Health On the Net Foundation. Click to verify.

This site complies with the HONcode standard for trustworthy health information:
verify here.

ABSTRACT

Title : COST-EFFECTIVENESS ANALYSIS OF ANTI-DIABETIC THERAPY IN A UNIVERSITY TEACHING HOSPITAL
Authors : Giwa Abdulganiyu, Tayo Fola
Keywords : Cost-Effectiveness Analysis, Pharmaco-Economics, Anti-Diabetic Therapy
Issue Date : March 2014
Abstract :
Purpose: To conduct cost-effectiveness analysis of anti-diabetic therapy in a University Teaching Hospital in 2010. Methods: A retrospective review of selected case-notes was conducted. World Health Organization Defined Daily Dose Method of evaluating drug use and probability method for potential effectiveness of anti-diabetic therapeutic options from literature analysis was employed in determining cost-effectiveness of each anti-diabetic therapeutic option identified from anti-diabetic drug utilization studies. Sample Size, n=1200. Subjects’ case-notes were selected by systematic random sampling (Sampling Interval = 1). Results: Glibenclamide (N1.76/unit of effectiveness) which was more cost-effective than chlopropamide (N2.97/unit of effectiveness) in the management of moderate hyperglycemia in non-obese Type II Diabetes Mellitus was more frequently prescribed (81.5%). Glibenclamide + Metformin (N7.63/unit of effectiveness) which was more frequently prescribed (92.5%) was not necessarily more cost-effective than Chlopropamide + Metformin (N9.76/unit of effectiveness) in the management of moderate hyperglycemia in obese Type II Diabetes- Mellitus. Biphasic Isophane Insulin (N12.65/unit of effectiveness) which was more cost-effective than soluble insulin + insulin zinc (N30.37/unit of effectiveness) in the management of serve hyperglycemia in non-obese Type II Diabetes Mellitus was less frequently prescribed (42.3%). Biphasic Isophane Insulin + Metformin (N15.91/unit of effectiveness ) which was more cost-effective than soluble insulin + insulin zinc + metformin (N34.45/ unit of effectiveness) in the management of severe hyperglycemia in obese Type II Diabetes Mellitus patients was less frequently prescribed (25%). Conclusions: Prescription of lees cost-effective anti-diabetic drugs was rampant in Hospitals.
Page(s) : 82-91
ISSN : 0975-9492
Source : Vol. 5, No.3